Search

Adam C. Krupicka

Examiner (ID: 14823, Phone: (571)270-7086 , Office: P/1784 )

Most Active Art Unit
1784
Art Unit(s)
1784, 1794
Total Applications
934
Issued Applications
542
Pending Applications
87
Abandoned Applications
327

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 12057068 [patent_doc_number] => 20170333412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-23 [patent_title] => 'METHOD FOR TREATING LYMPHEDEMA' [patent_app_type] => utility [patent_app_number] => 15/520008 [patent_app_country] => US [patent_app_date] => 2015-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 17994 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15520008 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/520008
Method for treating lymphedema Oct 19, 2015 Issued
Array ( [id] => 11942006 [patent_doc_number] => 20170246158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'ATROPINE SULFATE RAPIDLY-DISINTEGRATING SUBLINGUAL TABLETS, METHODS FOR MANUFACTURE THEREOF, AND METHODS FOR USE THEREOF FOR TREATMENT OF ACUTE ORGANOPHOSPHATE TOXICITY' [patent_app_type] => utility [patent_app_number] => 15/516444 [patent_app_country] => US [patent_app_date] => 2015-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9210 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516444 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/516444
ATROPINE SULFATE RAPIDLY-DISINTEGRATING SUBLINGUAL TABLETS, METHODS FOR MANUFACTURE THEREOF, AND METHODS FOR USE THEREOF FOR TREATMENT OF ACUTE ORGANOPHOSPHATE TOXICITY Oct 1, 2015 Pending
Array ( [id] => 10737183 [patent_doc_number] => 20160083333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-24 [patent_title] => 'FORMULATION COMPRISING ESTER QUATS BASED ON ISOPROPANOLAMINE AND TETRAHYDROXYPROPYL ETHYLENEDIAMINE' [patent_app_type] => utility [patent_app_number] => 14/861391 [patent_app_country] => US [patent_app_date] => 2015-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11656 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14861391 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/861391
Formulation comprising ester quats based on isopropanolamine and tetrahydroxypropyl ethylenediamine Sep 21, 2015 Issued
Array ( [id] => 11941997 [patent_doc_number] => 20170246148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-31 [patent_title] => 'Methods and Compositions for Treating Psychotic Disorders' [patent_app_type] => utility [patent_app_number] => 15/510218 [patent_app_country] => US [patent_app_date] => 2015-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 20602 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510218 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/510218
Methods and Compositions for Treating Psychotic Disorders Sep 14, 2015 Abandoned
Array ( [id] => 10467103 [patent_doc_number] => 20150352117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'COMBINATION' [patent_app_type] => utility [patent_app_number] => 14/829689 [patent_app_country] => US [patent_app_date] => 2015-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14985 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14829689 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/829689
COMBINATION Aug 18, 2015 Abandoned
Array ( [id] => 11895105 [patent_doc_number] => 09765029 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-09-19 [patent_title] => 'Pyridine compounds as sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 14/824319 [patent_app_country] => US [patent_app_date] => 2015-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29790 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14824319 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/824319
Pyridine compounds as sodium channel blockers Aug 11, 2015 Issued
Array ( [id] => 11755947 [patent_doc_number] => 20170202814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-20 [patent_title] => 'AGENTS FOR THE TREATMENT OF RETROVIRAL INFECTIOUS DISEASES' [patent_app_type] => utility [patent_app_number] => 15/324576 [patent_app_country] => US [patent_app_date] => 2015-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14502 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15324576 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/324576
Agents for the treatment of retroviral infectious diseases Jul 9, 2015 Issued
Array ( [id] => 11742818 [patent_doc_number] => 20170196891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'FATTY ACID BILE ACID CONJUGATES FOR TREATMENT OF LIPODYSTROPHY' [patent_app_type] => utility [patent_app_number] => 15/313640 [patent_app_country] => US [patent_app_date] => 2015-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9498 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313640 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/313640
FATTY ACID BILE ACID CONJUGATES FOR TREATMENT OF LIPODYSTROPHY May 30, 2015 Abandoned
Array ( [id] => 17350042 [patent_doc_number] => 11224660 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-01-18 [patent_title] => Stable cannabinoid formulations [patent_app_type] => utility [patent_app_number] => 14/724351 [patent_app_country] => US [patent_app_date] => 2015-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13815 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14724351 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/724351
Stable cannabinoid formulations May 27, 2015 Issued
Array ( [id] => 12098178 [patent_doc_number] => 09855260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-02 [patent_title] => 'Quinolinone derivatives' [patent_app_type] => utility [patent_app_number] => 14/708424 [patent_app_country] => US [patent_app_date] => 2015-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46761 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14708424 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/708424
Quinolinone derivatives May 10, 2015 Issued
Array ( [id] => 10684437 [patent_doc_number] => 20160030583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-04 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE' [patent_app_type] => utility [patent_app_number] => 14/709342 [patent_app_country] => US [patent_app_date] => 2015-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13914 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14709342 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/709342
PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE May 10, 2015 Abandoned
Array ( [id] => 11964907 [patent_doc_number] => 20170269060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'Assays and Compounds to Treat Kidney Diseases' [patent_app_type] => utility [patent_app_number] => 15/310350 [patent_app_country] => US [patent_app_date] => 2015-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15883 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310350 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/310350
Assays and Compounds to Treat Kidney Diseases May 7, 2015 Abandoned
Array ( [id] => 11574616 [patent_doc_number] => 09629857 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Therapeutic uses of glutathione mimics' [patent_app_type] => utility [patent_app_number] => 14/694699 [patent_app_country] => US [patent_app_date] => 2015-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 4690 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14694699 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/694699
Therapeutic uses of glutathione mimics Apr 22, 2015 Issued
Array ( [id] => 11462717 [patent_doc_number] => 09579331 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-28 [patent_title] => 'Therapeutic uses of glutathione mimics' [patent_app_type] => utility [patent_app_number] => 14/694729 [patent_app_country] => US [patent_app_date] => 2015-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 4689 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14694729 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/694729
Therapeutic uses of glutathione mimics Apr 22, 2015 Issued
Array ( [id] => 10346106 [patent_doc_number] => 20150231111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'METHODS OF TREATING SKIN CONDITIONS USING CYCLOLIGNAN COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/691238 [patent_app_country] => US [patent_app_date] => 2015-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8170 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14691238 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/691238
Methods of treating skin conditions using cyclolignan compounds Apr 19, 2015 Issued
Array ( [id] => 10311502 [patent_doc_number] => 20150196504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'CO-CRYSTALS OF TRAMADOL AND COXIBS' [patent_app_type] => utility [patent_app_number] => 14/665060 [patent_app_country] => US [patent_app_date] => 2015-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10235 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14665060 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/665060
CO-CRYSTALS OF TRAMADOL AND COXIBS Mar 22, 2015 Abandoned
Array ( [id] => 10311500 [patent_doc_number] => 20150196503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'CO-CRYSTALS OF TRAMADOL AND COXIBS' [patent_app_type] => utility [patent_app_number] => 14/665055 [patent_app_country] => US [patent_app_date] => 2015-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10236 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14665055 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/665055
CO-CRYSTALS OF TRAMADOL AND COXIBS Mar 22, 2015 Abandoned
Array ( [id] => 10297463 [patent_doc_number] => 20150182462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-02 [patent_title] => 'Opioid-Containing Oral Pharmaceutical Compositions and Methods' [patent_app_type] => utility [patent_app_number] => 14/644263 [patent_app_country] => US [patent_app_date] => 2015-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11910 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14644263 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/644263
Opioid-Containing Oral Pharmaceutical Compositions and Methods Mar 10, 2015 Abandoned
Array ( [id] => 15631883 [patent_doc_number] => 10588909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-17 [patent_title] => Modulators of HEC1 activity and methods therefor [patent_app_type] => utility [patent_app_number] => 14/645292 [patent_app_country] => US [patent_app_date] => 2015-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 40689 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645292 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/645292
Modulators of HEC1 activity and methods therefor Mar 10, 2015 Issued
Array ( [id] => 10289128 [patent_doc_number] => 20150174126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-25 [patent_title] => 'Pharmaceutical combination' [patent_app_type] => utility [patent_app_number] => 14/639265 [patent_app_country] => US [patent_app_date] => 2015-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8017 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14639265 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/639265
Pharmaceutical combination Mar 4, 2015 Abandoned
Menu